Terms: = Cervical cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
18 results:
1. Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
Gaudioso P; Borsetto D; Polesel J; Tirelli G; Emanuelli E; Menegaldo A; Molteni G; Nicolai P; Tomasoni M; Montenegro C; Piazza C; Bossi P; Ciorba A; Canzi P; Giacomarra V; Giudici F; Fussey J; Boscolo-Rizzo P
ORL J Otorhinolaryngol Relat Spec; 2024; 86(1):32-40. PubMed ID: 37972574
[TBL] [Abstract] [Full Text] [Related]
2. Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease.
Califano I; Smulever A; Jerkovich F; Pitoia F
Rev Endocr Metab Disord; 2024 Feb; 25(1):123-147. PubMed ID: 37648897
[TBL] [Abstract] [Full Text] [Related]
3. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.
Wang JR; Montierth M; Xu L; Goswami M; Zhao X; Cote G; Wang W; Iyer P; Dadu R; Busaidy NL; Lai SY; Gross ND; Ferrarotto R; Lu C; Gunn GB; Williams MD; Routbort M; Zafereo ME; Cabanillas ME
JCO Precis Oncol; 2022 Aug; 6():e2100504. PubMed ID: 35977347
[TBL] [Abstract] [Full Text] [Related]
5. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung cancer Patients-Comparison with the Standard Histopathological Procedure.
Vodicka J; Pesta M; Kulda V; Houfkova K; Vankova B; Sebek J; Skala M; Fichtl J; Prochazkova K; Topolcan O
Cells; 2020 Dec; 9(12):. PubMed ID: 33291819
[TBL] [Abstract] [Full Text] [Related]
7. MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.
Singh N; Bhakuni R; Chhabria D; Kirubakaran S
BMC Res Notes; 2020 Mar; 13(1):146. PubMed ID: 32160908
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
[TBL] [Abstract] [Full Text] [Related]
9. Impact of tumor-associated macrophages and BRAF
Cho JW; Kim WW; Lee YM; Jeon MJ; Kim WG; Song DE; Park Y; Chung KW; Hong SJ; Sung TY
Head Neck; 2019 Mar; 41(3):686-691. PubMed ID: 30659691
[TBL] [Abstract] [Full Text] [Related]
10. microRNA-136 inhibits proliferation and promotes apoptosis and radiosensitivity of cervical carcinoma through the NF-κB pathway by targeting E2F1.
Lu HJ; Jin PY; Tang Y; Fan SH; Zhang ZF; Wang F; Wu DM; Lu J; Zheng YL
Life Sci; 2018 Apr; 199():167-178. PubMed ID: 29452167
[TBL] [Abstract] [Full Text] [Related]
11. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.
Chen S; Tao M; Zhao L; Zhang X
Medicine (Baltimore); 2017 Oct; 96(40):e7981. PubMed ID: 28984757
[TBL] [Abstract] [Full Text] [Related]
12. ADC Histogram Analysis of cervical cancer Aids Detecting Lymphatic Metastases-a Preliminary Study.
Schob S; Meyer HJ; Pazaitis N; Schramm D; Bremicker K; Exner M; Höhn AK; Garnov N; Surov A
Mol Imaging Biol; 2017 Dec; 19(6):953-962. PubMed ID: 28315203
[TBL] [Abstract] [Full Text] [Related]
13. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
[TBL] [Abstract] [Full Text] [Related]
14. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Gómez Sáez JM; Jiménez-Fonseca P; Santamaría Sandi J; Capdevila Castillón J; Navarro González E; Zafón Llopis C; Ramón Y Cajal Asensio T; Riesco Eizaguirre G; Grande Pulido E; Galofré Ferrater JC
Endocrinol Nutr; 2015 Mar; 62(3):e15-22. PubMed ID: 25583658
[TBL] [Abstract] [Full Text] [Related]
15. Current treatment of papillary thyroid microcarcinoma.
Yu XM; Lloyd R; Chen H
Adv Surg; 2012; 46():191-203. PubMed ID: 22873040
[TBL] [Abstract] [Full Text] [Related]
16. Results of combined treatment of anaplastic thyroid carcinoma (atc).
Derbel O; Limem S; Ségura-Ferlay C; Lifante JC; Carrie C; Peix JL; Borson-Chazot F; Bournaud C; Droz JP; de la Fouchardière C
BMC Cancer; 2011 Nov; 11():469. PubMed ID: 22044775
[TBL] [Abstract] [Full Text] [Related]
17. [A retrospective analysis of anaplastic thyroid carcinoma].
Zhang ZM; Xu ZG; Tang PZ; Xue LY; Lü N
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):322-4. PubMed ID: 16900624
[TBL] [Abstract] [Full Text] [Related]
18. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
Are C; Shaha AR
Ann Surg Oncol; 2006 Apr; 13(4):453-64. PubMed ID: 16474910
[TBL] [Abstract] [Full Text] [Related]
